Cargando…
Clinical Management of Squamous Cell Carcinoma of the Conjunctiva
Patient: Female, 33-year-old Final Diagnosis: Conjunctival squamous cell carcinoma Symptoms: Tumorous lesion on the nasal bulbar conjunctiva • red eye Medication: — Clinical Procedure: The conjunctival tumor was excised. The histopathological diagnosis suggested a conjunctival squamous cell carcinom...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011170/ https://www.ncbi.nlm.nih.gov/pubmed/32005796 http://dx.doi.org/10.12659/AJCR.919751 |
_version_ | 1783496020036943872 |
---|---|
author | Röck, Tobias Bartz-Schmidt, Karl Ulrich Bramkamp, Matthias Milla, Jakob Bösmüller, Hans-Christian Röck, Daniel |
author_facet | Röck, Tobias Bartz-Schmidt, Karl Ulrich Bramkamp, Matthias Milla, Jakob Bösmüller, Hans-Christian Röck, Daniel |
author_sort | Röck, Tobias |
collection | PubMed |
description | Patient: Female, 33-year-old Final Diagnosis: Conjunctival squamous cell carcinoma Symptoms: Tumorous lesion on the nasal bulbar conjunctiva • red eye Medication: — Clinical Procedure: The conjunctival tumor was excised. The histopathological diagnosis suggested a conjunctival squamous cell carcinoma. A treatment with topical MMC was admistered Specialty: Ophthalmology OBJECTIVE: Rare disease BACKGROUND: Conjunctival squamous cell carcinoma is the most common non-pigmented malignancy of the ocular surface. This report illustrates the clinical management of squamous cell carcinoma of the conjunctiva. CASE REPORT: A 33-year-old female was referred to our eye hospital with a tumorous lesion on the nasal bulbar conjunctiva of the right eye. A topical therapy with antibiotic and corticosteroid eye drops did not change the lesion. The conjunctival tumor was widely resected. The histopathological diagnosis suggested a squamous cell carcinoma. After resection, a treatment with topical mitomycin C (MMC) 0.02% eye drops were started 4 times daily for 14 days. Two cycles of treatment were done with a 2-week interval during which only artificial tears eye drops were administered. At the 12-month follow-up, there was no sign of recurrence. CONCLUSIONS: This case illustrates the effective and successful clinical management of squamous cell carcinoma of the conjunctiva with excision and postoperative treatment with MMC 0.02% eye drops. |
format | Online Article Text |
id | pubmed-7011170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70111702020-02-24 Clinical Management of Squamous Cell Carcinoma of the Conjunctiva Röck, Tobias Bartz-Schmidt, Karl Ulrich Bramkamp, Matthias Milla, Jakob Bösmüller, Hans-Christian Röck, Daniel Am J Case Rep Articles Patient: Female, 33-year-old Final Diagnosis: Conjunctival squamous cell carcinoma Symptoms: Tumorous lesion on the nasal bulbar conjunctiva • red eye Medication: — Clinical Procedure: The conjunctival tumor was excised. The histopathological diagnosis suggested a conjunctival squamous cell carcinoma. A treatment with topical MMC was admistered Specialty: Ophthalmology OBJECTIVE: Rare disease BACKGROUND: Conjunctival squamous cell carcinoma is the most common non-pigmented malignancy of the ocular surface. This report illustrates the clinical management of squamous cell carcinoma of the conjunctiva. CASE REPORT: A 33-year-old female was referred to our eye hospital with a tumorous lesion on the nasal bulbar conjunctiva of the right eye. A topical therapy with antibiotic and corticosteroid eye drops did not change the lesion. The conjunctival tumor was widely resected. The histopathological diagnosis suggested a squamous cell carcinoma. After resection, a treatment with topical mitomycin C (MMC) 0.02% eye drops were started 4 times daily for 14 days. Two cycles of treatment were done with a 2-week interval during which only artificial tears eye drops were administered. At the 12-month follow-up, there was no sign of recurrence. CONCLUSIONS: This case illustrates the effective and successful clinical management of squamous cell carcinoma of the conjunctiva with excision and postoperative treatment with MMC 0.02% eye drops. International Scientific Literature, Inc. 2020-02-01 /pmc/articles/PMC7011170/ /pubmed/32005796 http://dx.doi.org/10.12659/AJCR.919751 Text en © Am J Case Rep, 2020 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Articles Röck, Tobias Bartz-Schmidt, Karl Ulrich Bramkamp, Matthias Milla, Jakob Bösmüller, Hans-Christian Röck, Daniel Clinical Management of Squamous Cell Carcinoma of the Conjunctiva |
title | Clinical Management of Squamous Cell Carcinoma of the Conjunctiva |
title_full | Clinical Management of Squamous Cell Carcinoma of the Conjunctiva |
title_fullStr | Clinical Management of Squamous Cell Carcinoma of the Conjunctiva |
title_full_unstemmed | Clinical Management of Squamous Cell Carcinoma of the Conjunctiva |
title_short | Clinical Management of Squamous Cell Carcinoma of the Conjunctiva |
title_sort | clinical management of squamous cell carcinoma of the conjunctiva |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011170/ https://www.ncbi.nlm.nih.gov/pubmed/32005796 http://dx.doi.org/10.12659/AJCR.919751 |
work_keys_str_mv | AT rocktobias clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva AT bartzschmidtkarlulrich clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva AT bramkampmatthias clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva AT millajakob clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva AT bosmullerhanschristian clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva AT rockdaniel clinicalmanagementofsquamouscellcarcinomaoftheconjunctiva |